Status:
COMPLETED
Absorb GT1 Japan PMS
Lead Sponsor:
Abbott Medical Devices
Conditions:
Ischemic Heart Disease
Angina Pectoris
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of the Surveillance is to know the frequency and status of adverse device effects and adverse events in order to assure the safety of the new medical device, and to collect efficacy and sa...
Eligibility Criteria
Inclusion
- General Percutaneous coronary intervention (PCI) population.
Exclusion
- No specific exclusion criteria.
Key Trial Info
Start Date :
December 13 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 6 2023
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT03409731
Start Date
December 13 2016
End Date
February 6 2023
Last Update
August 6 2024
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Nagoya Daini Red Cross Hospital
Nagoya, Aichi-ken, Japan, 466-8650
2
Shin Tokyo Hospital
Matsudo, Chiba, Japan, 270-2232
3
Shin Koga Hospital
Kurume, Fukuoka, Japan, 830-8577
4
Hanaoka Seishu Memorial Cardiovascular Clinic
Sapporo, Hokkaido, Japan, 062-0003